Zhang Chuxin, Chang Xing, Zhao Dandan, He Yu, Dong Guangtong, Gao Lin
Beijing University of Chinese Medicine, Beijing, 100029, China.
Guang'anmen Hospital of Chinese Academy of Traditional Chinese Medicine, Beijing, 100053, China.
J Pharm Anal. 2025 Feb;15(2):101051. doi: 10.1016/j.jpha.2024.101051. Epub 2024 Jul 23.
Ischemic heart disease (IHD) is associated with high morbidity and mortality rates. Reperfusion therapy is the best treatment option for this condition. However, reperfusion can aggravate myocardial damage through a phenomenon known as myocardial ischemia/reperfusion (I/R) injury, which has recently gained the attention of researchers. Several studies have shown that Chinese herbal medicines and their natural monomeric components exert therapeutic effects against I/R injury. This review outlines the current knowledge on the pathological mechanisms through which mitochondria participate in I/R injury, focusing on the issues related to energy metabolism, mitochondrial quality control disorders, oxidative stress, and calcium. The mechanisms by which mitochondria mediate cell death have also been discussed. To develop a resource for the prevention and management of clinical myocardial I/R damage, we compiled the most recent research on the effects of Chinese herbal remedies and their monomer components.
缺血性心脏病(IHD)的发病率和死亡率都很高。再灌注疗法是治疗这种疾病的最佳选择。然而,再灌注会通过一种称为心肌缺血/再灌注(I/R)损伤的现象加重心肌损伤,这种现象最近引起了研究人员的关注。多项研究表明,中草药及其天然单体成分对I/R损伤具有治疗作用。本综述概述了线粒体参与I/R损伤的病理机制的当前知识,重点关注与能量代谢、线粒体质量控制障碍、氧化应激和钙相关的问题。还讨论了线粒体介导细胞死亡的机制。为了开发预防和管理临床心肌I/R损伤的资源,我们汇编了关于中草药及其单体成分作用的最新研究。